United States Antimony Expands Capacity as Defense Contracts Fuel Growth

United States Antimony (UAMY) is expanding capacity due to defense contracts, including a $245M DLA contract for antimony metal ingots. The company also secured a $106M contract for flame-retardant materials. A joint venture with Americas Gold and Silver aims to build a hydrometallurgical facility, increasing total capacity to 1,500 tons/month. Revenue grew from $8M in 2023 to $39M in 2024, but guidance was reduced to $60M-$75M due to price declines.

Original reporting
Published Oct 21, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
United States Antimony Expands Capacity as Defense Contracts Fuel Growth — source image
Decision brief

The 30-second read

$UAMYNeutralMed
01

Why it matters

The $245 M defense contract and guidance reduction together reshape near‑term earnings expectations.

02

Market read

New defense contract offsets guidance cut, creating mixed short‑term price pressure for UAMY.

03

What to watch

Potential for additional contract expansions and tungsten revenue line could improve future outlook.

Relevance 8/10Novelty 8/10Timing: today

Background

United States Antimony (NYSE:UAMY) produces antimony and related specialty materials, serving defense and industrial markets.

Company-level read

Ticker impact

$UAMYNeutralHigh confidence
Context

United States Antimony disclosed a $245 million Defense Logistics Agency contract and cut its 2025 revenue guidance to $60‑75 million after antimony price weakness.

Expected impact

likely pressure as the market prices in the lower revenue guidance despite the new contract

Evidence & confidence

Guidance cut is a material negative; the contract is a positive but may be offset in the short term.

Market effects

U.S. specialty metals and defense supply chain may see modest demand uplift.

U.S. defense contractors could benefit from increased antimony supply.

Limited to antimony market; no broad macro effect.

Counterpoint

The defense contract could outweigh the guidance cut if execution is swift, leading to upside.

Key entities

  • United States Antimony Corporation

    U.S. antimony producer listed on NYSE.

  • Defense Logistics Agency

    U.S. defense procurement agency awarding the contract.

Related articles

$UAMYMed

United States Antimony Corporation Reports Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results

UNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 United States Antimony Corporation Reports Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results Third Quarter 2026 Revenues Increased 16% to $10.1 Million Antimony pounds sold up 68% in the quarter Gross Profit Margin Expands to 42%

$UAMYHigh

United States Antimony Surges 19% Ahead of Earnings; USA Rare Earth Climbs 7%, Critical Metals Rises 4%

United States Antimony (UAMY) surged 19% to $3.36 ahead of its Q3 2026 earnings report. USA Rare Earth (USAR) and Critical Metals (CRML) also rose 7% and 4%, respectively. UAMY's jump is attributed to anticipation of its earnings and broader market interest in critical minerals. The company's Q2 2026 report showed a GAAP EPS of $0.00, beating estimates, but sales missed expectations. Management expects margin improvements in the second half of 2026.

$UAMYMed

Critical Minerals Stocks Rally as Sector Bid Broadens: United States Antimony and USA Rare Earth Jump 11%, Critical Metals Climbs 8%

United States Antimony (UAMY) and USA Rare Earth (USAR) stocks rose 11%, while Critical Metals (CRML) climbed 8%, driven by sector-wide buying in critical minerals. UAMY reported a $314M resource valuation for its Nolan Creek property, and CRML completed its acquisition of European Lithium. The VanEck Rare Earth ETF (REMX) gained 4%, outperforming the broader market.

$CRMLMed

Critical Metals Sinks 7% Despite Shareholder Approval of European Lithium Deal; USA Rare Earth Drops 5%, United States Antimony Falls 3%

Critical Metals (CRML) shares fell 7% despite shareholder approval of its acquisition of European Lithium, which would grant full control of a Greenland rare earth project. USA Rare Earth (USAR) and United States Antimony (UAMY) also declined 5% and 3%, respectively. The VanEck Rare Earth ETF (REMX) dropped 3%, while the broader market (SPY) fell 1%. The deal awaits court approval and new shares are expected to begin trading in early November.

$UAMYHigh

United States Antimony Soars 11% While Rare Earth Peers Retreat; USA Rare Earth Drops 3%, Critical Metals Falls 4%

United States Antimony (UAMY) rose 11% to $3.18, while USA Rare Earth (USAR) fell 3% and Critical Metals (CRML) dropped 4%. UAMY benefits from a $245M Defense Logistics Agency contract, with Q3 2026 deliveries increasing. The company cut revenue guidance to $60M-$75M but expects antimony prices to stay around $10/lb. USAR and CRML focus on rare earth elements, with USAR expanding its supply chain and CRML awaiting project approvals.